A new analysis of hypertension guidelines suggests some older adults — mostly women — with slightly high blood pressure could safely hold off on medications if they’re in good health.
A new study published in the Journal American Medical Association showed that patients with an Cystatin C based estimated ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
MedPage Today on MSN
Drug Cuts Albuminuria in Type 1 Diabetic Kidney Disease, Too
First new drug in 30 years to slow kidney disease in type 1 diabetes ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...
Diabetes is one of the leading causes of kidney disease worldwide, and India carries a particularly high burden of both conditions. What makes diabetic kidney disease especially concerning is that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results